{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:45:24Z","timestamp":1787064324099,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160100"],"award-info":[{"award-number":["82160100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060047"],"award-info":[{"award-number":["82060047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81770472"],"award-info":[{"award-number":["81770472"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangxi Science and Technology Base and Special Talents\u2019 Project","award":["GK AD17129026"],"award-info":[{"award-number":["GK AD17129026"]}]},{"name":"Guangxi Science and Technology Specialized Project","award":["GKG 14124003-9"],"award-info":[{"award-number":["GKG 14124003-9"]}]},{"name":"Fund Project of Guangxi Zhuang Autonomous Region Health Commission","award":["S2020116-1"],"award-info":[{"award-number":["S2020116-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with end-stage renal disease (ESRD) face a significantly elevated risk of cardiovascular morbidity and mortality, with left ventricular (LV) systolic dysfunction and heart failure (HF) being major contributors. Reduced left ventricular ejection fraction (LVEF) defines LV systolic dysfunction and is closely linked to adverse outcomes. This study aimed to assess the prevalence of abnormal LVEF in ESRD patients receiving hemodialysis and to examine the prognostic significance of varying LVEF levels on mortality and cardiovascular outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort study was conducted on 1,019 ESRD patients receiving hemodialysis at People\u2019s Hospital of Guangxi Zhuang Autonomous Region between January 1, 2020, and December 31, 2021. Based on baseline LVEF, patients were classified into three groups: reduced ejection fraction (LVEF\u2009\u2264\u200940%, rEF), mildly reduced ejection fraction (LVEF 41\u201349%, mrEF), and normal ejection fraction (LVEF\u2009\u2265\u200950%, nEF). Clinical outcomes, including all-cause mortality and major adverse cardiovascular events (MACEs), were analyzed to assess the impact of LVEF levels. During a median follow-up of 35 months (IQR, 31\u201351 months), 214 patients (21.0%) died, and 218 (21.4%) experienced MACEs. The prevalence of abnormal LVEF was 13.35%, with 7.55% of patients in the mrEF group and 5.80% in the rEF group. Patients with abnormal LVEF showed significantly higher rates of all-cause mortality and MACEs than those with normal LVEF. In the rEF group, the odds ratios (ORs) for all-cause mortality and MACEs were 2.91 (95% CI: 1.83\u20134.63,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and 4.76 (95% CI: 2.43\u20139.46,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), respectively. In the mrEF group, ORs for all-cause mortality and MACEs were 1.69 (95% CI: 1.09\u20132.62,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.019) and 2.68 (95% CI: 1.54\u20134.68,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Abnormal LVEF is prevalent in ESRD patients on hemodialysis and is strongly associated with increased risks of all-cause mortality and MACEs. Lower LVEF levels correlate with poorer outcomes, underscoring the importance of early detection and targeted management strategies to improve prognosis in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-025-04316-8","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T16:49:35Z","timestamp":1752338975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease"],"prefix":"10.1186","volume":"26","author":[{"given":"Qingkuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoming","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"Suppl 2","key":"4316_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000488123","volume":"72","author":"A Levin","year":"2018","unstructured":"Levin A. Improving global kidney health: international society of nephrology initiatives and the global kidney health atlas. Ann Nutr Metab. 2018;72(Suppl 2):28\u201332. https:\/\/doi.org\/10.1159\/000488123.","journal-title":"Ann Nutr Metab"},{"key":"4316_CR2","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382. https:\/\/doi.org\/10.1016\/S0140-6736(14)61601-9.","journal-title":"Lancet"},{"key":"4316_CR3","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.2215\/CJN.00050110","volume":"5","author":"S Yamada","year":"2010","unstructured":"Yamada S, Ishii H, Takahashi H, Aoyama T, Morita Y, Kasuga H, Kimura K, Ito Y, Takahashi R, Toriyama T, et al. Prognostic value of reduced left ventricular ejection fraction at start of Hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol. 2010;5:1793\u20138. https:\/\/doi.org\/10.2215\/CJN.00050110.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4316_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fmed.2018.00206","volume":"5","author":"PG de Albuquerque Suassuna","year":"2018","unstructured":"de Albuquerque Suassuna PG, Sanders-Pinheiro H, de Paula RB. Uremic cardiomyopathy: A new piece in the chronic kidney Disease-Mineral and bone disorder puzzle. Front Med (Lausanne). 2018;5:206. https:\/\/doi.org\/10.3389\/fmed.2018.00206.","journal-title":"Front Med (Lausanne)"},{"key":"4316_CR5","doi-asserted-by":"publisher","unstructured":"Eyad Alhaj 1 NA, Ifad Rahman TO, Niazi R, Berkowitz M. Klapholz. Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail. 2013;Jul-Aug;19(4):E40-5. https:\/\/doi.org\/10.1111\/chf.12030. Epub 2013 Apr 25.","DOI":"10.1111\/chf.12030"},{"key":"4316_CR6","doi-asserted-by":"crossref","unstructured":"Johansen KL, Gilbertson DT, Li S, Li S, Liu J, Roetker NS, Ku E, Schulman IH, Greer RC, Chan K, et al. Epidemiology of Kidney Disease in the United States. Am j kidney dis. 2024;83:A8\u201313. US Renal Data System 2023 Annual Data Report.","DOI":"10.1053\/j.ajkd.2024.01.001"},{"key":"4316_CR7","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jacc.2021.01.028","volume":"77","author":"AC Lai","year":"2021","unstructured":"Lai AC, Bienstock SW, Sharma R, Skorecki K, Beerkens F, Samtani R, Coyle A, Kim T, Baber U, Camaj A, et al. A personalized approach to chronic kidney disease and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol. 2021;77:1470\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"4316_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.ajkd.2005.01.019","volume":"45","author":"K\/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients","year":"2005","unstructured":"K\/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45:16\u2013153. https:\/\/doi.org\/10.1053\/j.ajkd.2005.01.019.","journal-title":"Am J Kidney Dis"},{"key":"4316_CR9","doi-asserted-by":"crossref","unstructured":"Marx-Sch\u00fctt K, Cherney DZI, Jankowski J, Matsushita K, Nardone M, Marx N. Cardiovascular disease in chronic kidney disease. Eur heart j. 2025;null:null.","DOI":"10.1093\/eurheartj\/ehaf167"},{"key":"4316_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/s0272-6386(03)00359-7","volume":"41","author":"FC Trespalacios","year":"2003","unstructured":"Trespalacios FC, Taylor AJ, Agodoa LY, Bakris GL, Abbott KC. Heart failure as a cause for hospitalization in chronic dialysis patients. Am J Kidney Dis. 2003;41:1267\u201377. https:\/\/doi.org\/10.1016\/s0272-6386(03)00359-7.","journal-title":"Am J Kidney Dis"},{"key":"4316_CR11","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"4316_CR12","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/ejhf.945","volume":"19","author":"AS Koh","year":"2017","unstructured":"Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, Savarese G, Lam CSP, Lund LH. A comprehensive population-based characterization of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2017;19:1624\u201334. https:\/\/doi.org\/10.1002\/ejhf.945.","journal-title":"Eur J Heart Fail"},{"key":"4316_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ejhf.1077","volume":"20","author":"LCR Hensen","year":"2018","unstructured":"Hensen LCR, Goossens K, Delgado V, Abou R, Rotmans JI, Jukema JW, Bax JJ. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction. Eur J Heart Fail. 2018;20:560\u20138. https:\/\/doi.org\/10.1002\/ejhf.1077.","journal-title":"Eur J Heart Fail"},{"key":"4316_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.kint.2021.09.024","volume":"101","author":"MSY Ng","year":"2022","unstructured":"Ng MSY, Charu V, Johnson DW, O\u2019Shaughnessy MM, Mallett AJ. National and international kidney failure registries: characteristics, commonalities, and contrasts. Kidney Int. 2022;101:23\u201335. https:\/\/doi.org\/10.1016\/j.kint.2021.09.024.","journal-title":"Kidney Int"},{"key":"4316_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ki.2011.223","volume":"80","author":"CA Herzog","year":"2011","unstructured":"Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, et al. Cardiovascular disease in chronic kidney disease. A clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80:572\u201386. https:\/\/doi.org\/10.1038\/ki.2011.223.","journal-title":"Kidney Int"},{"key":"4316_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2215\/CJN.06020612","volume":"8","author":"N Bansal","year":"2013","unstructured":"Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, et al. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013;8:355\u201362. https:\/\/doi.org\/10.2215\/CJN.06020612.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4316_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ajkd.2018.02.363","volume":"72","author":"N Bansal","year":"2018","unstructured":"Bansal N, Roy J, Chen HY, Deo R, Dobre M, Fischer MJ, Foster E, Go AS, He J, Keane MG, et al. Evolution of echocardiographic measures of cardiac disease from CKD to ESRD and risk of All-Cause mortality: findings from the CRIC study. Am J Kidney Dis. 2018;72:390\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2018.02.363.","journal-title":"Am J Kidney Dis"},{"key":"4316_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s42399-022-01347-2","volume":"5","author":"A Minciunescu","year":"2023","unstructured":"Minciunescu A, Genovese L, deFilippi C. Cardiovascular alterations and structural changes in the setting of chronic kidney disease: a review of cardiorenal syndrome type 4. SN Compr Clin Med. 2023;5:15. https:\/\/doi.org\/10.1007\/s42399-022-01347-2.","journal-title":"SN Compr Clin Med"},{"key":"4316_CR19","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure Long-Term registry. Eur J Heart Fail. 2017;19:1574\u201385. https:\/\/doi.org\/10.1002\/ejhf.813.","journal-title":"Eur J Heart Fail"},{"key":"4316_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/ac.68.1.2959632","volume":"68","author":"D Derthoo","year":"2013","unstructured":"Derthoo D, Belmans A, Claes K, Bammens B, Ciarka A, Droogne W, Vanhaecke J, Van Cleemput J, Janssens S. Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective study. Acta Cardiol. 2013;68:51\u20137. https:\/\/doi.org\/10.1080\/ac.68.1.2959632.","journal-title":"Acta Cardiol"},{"key":"4316_CR21","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/ejhf.1058","volume":"19","author":"JF Nauta","year":"2017","unstructured":"Nauta JF, Hummel YM, van Melle JP, van der Meer P, Lam CSP, Ponikowski P, Voors AA. What have we learned about heart failure with mid-range ejection fraction one year after its introduction? Eur J Heart Fail. 2017;19:1569\u201373. https:\/\/doi.org\/10.1002\/ejhf.1058.","journal-title":"Eur J Heart Fail"},{"key":"4316_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000168084","volume":"10","author":"PS Parfrey","year":"1990","unstructured":"Parfrey PS, Griffiths SM, Harnett JD, Taylor R, King A, Hand J, Barre PE. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. Am J Nephrol. 1990;10:213\u201321. https:\/\/doi.org\/10.1159\/000168084.","journal-title":"Am J Nephrol"},{"key":"4316_CR23","doi-asserted-by":"publisher","unstructured":"Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, Okpechi IG, Salako BL, Wiebe N, Ye F, et al. Global kidney health atlas (GKHA): design and methods. Kidney Int Suppl (2011). 2017;7:145\u201353. https:\/\/doi.org\/10.1016\/j.kisu.2017.08.001.","DOI":"10.1016\/j.kisu.2017.08.001"},{"key":"4316_CR24","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American heart association. Circulation. 2019;139:e840\u201378. https:\/\/doi.org\/10.1161\/CIR.0000000000000664.","journal-title":"Circulation"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04316-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:38:47Z","timestamp":1757227127000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04316-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4316"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04316-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adheres to the principles of the Declaration of Helsinki and has received approval from the Ethics Committee of the People\u2019s Hospital of Guangxi Zhuang Autonomous Region (KY-SY-2020-5). All participants provided written informed consent before the start of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"384"}}